Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Published Date: 06 Mar 2023

USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...

Read Full News

Latest News

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

Why Patients Miss Dialysis Treatments, With Steven Brunelli, MD Steven Brunelli, MD

A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

ATTACK: Should Patients With CKD Start Aspirin for Primary Prevention? Hugh Gallagher, MD

Hugh Gallagher, MBBS, PhD, discusses a 27% lower point estimate for cardiovascular events with aspirin that was not significant.

Todays Updates

STABLE Trial: Breath-Hold Does Not Improve Robotic Bronchoscopy Yield Roshen Mathew, MD, DAABIP

Roshen Mathew, MD, DAABIP, discusses STABLE, in which diagnostic yield was 86.8% with breath-hold vs 92.2% with conventional ventilation.

Insights on the Updated 2026 AHA/ASA Stroke Rehabilitation Guidelines Louie Pasculli, Talya Fleming, MD, Sara Cuccurullo, MD

Sara Cuccurullo, MD, FAAPMR, and Talya Fleming, MD, FAAPMR, of Hackensack Meridian JFK Johnson Rehabilitation Institute, discuss the updated adult stroke rehabilitation and recovery guidelines and their implications for clinical practice.

Todays Updates

STABLE Trial: Breath-Hold Does Not Improve Robotic Bronchoscopy Yield Roshen Mathew, MD, DAABIP

Roshen Mathew, MD, DAABIP, discusses STABLE, in which diagnostic yield was 86.8% with breath-hold vs 92.2% with conventional ventilation.

Insights on the Updated 2026 AHA/ASA Stroke Rehabilitation Guidelines Louie Pasculli, Talya Fleming, MD, Sara Cuccurullo, MD

Sara Cuccurullo, MD, FAAPMR, and Talya Fleming, MD, FAAPMR, of Hackensack Meridian JFK Johnson Rehabilitation Institute, discuss the updated adult stroke rehabilitation and recovery guidelines and their implications for clinical practice.

Latest News

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

Hugh Gallagher, MBBS, PhD, discusses a 27% lower point estimate for cardiovascular events with aspirin that was not significant.

News All Time

What MEnD-AKI Revealed About AI Alerts, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

AI Alerts Did Not Reduce Kidney Events, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D Phoom Narongkiatikhun, MD

Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Robotics and Organ Preservation in Transplant, With Ari Cohen, MD Ari Cohen, MD, MBA

An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.

Ochsner Health Expands Liver Transplant Access Through Multidisciplinary Care Ari Cohen, MD, MBA

Ochsner Health uses multidisciplinary clinics, living donor programs, and transplant innovations to address access challenges.

Atacicept Slows IgAN Decline to Physiologic Rate, With Sayna Norouzi, MD Sayna Norouzi, MD

Final ORIGIN 3 analysis shows a 76% lower risk of kidney disease progression vs placebo through 2 years.

How Glomerular Disease Shapes Young Women's Life Choices, With Sayna Norouzi, MD Sayna Norouzi, MD

An AHA statement co-author says reproductive and family planning concerns belong in kidney care for women with glomerular disease.

Pregnancy After Living Kidney Donation, With Amit X. Garg, MD, PhD Amit X. Garg, MD, PhD

Amit X. Garg, MD, PhD, discusses new JAMA data on preeclampsia risk after living kidney donation in a 3-part video interview.

Felzartamab and the Hidden Injury of Isolated MVI, With Yasir Qazi, MD Yasir Qazi, MD

TRANSPIRE investigator Yasir Qazi, MD, explains how isolated MVI can signal kidney transplant injury before creatinine rises.

I CAN: Ravulizumab Cuts Proteinuria 43% vs Placebo in IgA Nephropathy

I CAN: Ravulizumab Cuts Proteinuria 43% vs Placebo in IgA Nephropathy

Lorundrostat Lowers BP, Albuminuria in CKD With Uncontrolled Hypertension

Lorundrostat Lowers BP, Albuminuria in CKD With Uncontrolled Hypertension

TELIGAN: Telitacicept Preserves eGFR Through 2 Years in IgA Nephropathy Abigail Brooks, MA

Final TELIGAN data show telitacicept cut confirmed 30% eGFR decline by 89% and reduced proteinuria by 60.7% vs placebo over 2 years in IgA nephropathy.

IMAgINATION: Sefaxersen Meets Phase 3 Proteinuria Endpoint in IgA Nephropathy

IMAgINATION: Sefaxersen Meets Phase 3 Proteinuria Endpoint in IgA Nephropathy

RAINIER: Povetacicept Cuts Proteinuria, Gd-IgA1 in IgA Nephropathy

RAINIER: Povetacicept Cuts Proteinuria, Gd-IgA1 in IgA Nephropathy

Inside FIND-CKD: The Data Behind the Trial's 23% Risk Reduction Brendon Neuen, MBBS, PhD, Shikha Wadhwani, MD, MS

Brendan Neuen breaks down the full FIND-CKD primary and secondary endpoint data, subgroup consistency, and safety signals.

Recommended News For You

Slowdown in progress found with cancer survival in England and Wales

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care

FDA Approves Hemophilia B Second Gene Therapy.

ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Recommended Articles For You

Case Study: Genomic Medicine in Precision Oncology 

Exploring the Role of Fecal Leukocytes in Intestinal Health 

Chronic Disease Clustering in Communities: Epidemiology, Mechanisms, and Clinical Implications 

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

2.

Colon cancer and exercise: Can physical activity reprogram genes?

3.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

4.

AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI

5.

When does a melanoma metastasize? Implications for management

1.

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies

2.

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases

3.

Screening for Treatment-Related Sarcopenia in Cancer Care

4.

Tumor Ecosystem Rewiring Through Adaptive Therapeutics

5.

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

4.

Navigating the Complexities of Ph Negative ALL - Part VII

5.

Managing Supportive Care During Platelet Recovery

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot